EUROEYES (01846): Marcus Huascar Bracklo Transferred from Non-Executive Director to Executive Director

Stock News
2025/08/25

EUROEYES (01846) announced that Dr. Markus Braun has tendered his resignation as executive director and chief financial officer of the company due to his personal career development plans. He will also cease to serve as (i) the company's authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the company's authorized representative for receiving legal process documents and notices on behalf of the company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from September 14, 2025.

Mr. Marcus Huascar Bracklo has been transferred from non-executive director to executive director and appointed as chief financial officer, effective from September 14, 2025.

Effective from September 14, 2025: (a) Mr. Bracklo will no longer serve as a member of the audit committee; (b) Ms. Katherine Rong Xin, an independent non-executive director, will be appointed as a member of the audit committee; and (c) the audit committee will comprise Mr. Philip Duncan Wright (chairman), Mr. Hans Helmuth Hennig, and Ms. Xin.

Following his appointment and effective from September 14, 2025, Mr. Bracklo has been appointed as the authorized representative under the Listing Rules and the authorized representative and agent for service of process under the Companies Ordinance, filling the vacancy left by Dr. Braun.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10